Related Experiment Video
Updated: Aug 8, 2026
Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization
Published on: August 16, 2015
Interpreting cell cycle effects of drugs: the case of melphalan
Monica Lupi1, Paolo Cappella, Giada Matera
1Biophysics Unit, Laboratory of Cancer Pharmacology, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157, Milano, Italy. ubezio@marionegri.it
Abstract:
Multiple effects usually occur in the cell cycle, during and after the exposure to a drug, while treated cells flowing through the cycle encounter G1, S and G2M checkpoints. We developed a simulation tool connecting the microscopic level of the cellular response in G1, S and G2M with the experimental data of growth inhibition and flow cytometry. We found that multiple-often not intuitive-combinations of cytostatic and cytotoxic effects can be in keeping with the observations. This multiplicity of interpretation can be strongly reduced by considering together data with different methods, ideally reaching a reconstruction of the underlying cell cycle perturbations. Here, we propose an experimental plan including a time course of DNA flow cytometry and absolute cell count measurements with several drug concentrations and a limited number of flow cytometric DNA-Bromodeoxyuridine and TUNEL analyses, coupled with computer simulation. We showed its use in the attempt to define the complete time course of the effects of melphalan on three cancer cell lines. After drug treatment, each subset of cells experienced blocks and lethality in all phases of the cell cycle, but the dynamics was different, the differences being strongly dose-dependent. Our approach allows a better appreciation of the complexity of the cell cycle phenomena associated with drug treatment. It is expected that such level of understanding of the time- and dose-dependence of the cytostatic and cytotoxic effects of a drug might support rational therapeutic design.
Insights
This study introduces a simulation tool to analyze drug effects on the cell cycle, integrating microscopic data with experimental results. This approach clarifies complex drug-induced cell cycle perturbations for better therapeutic design.
Area of Science:
- Pharmacology
- Cell Biology
- Computational Biology
Background:
- Drug treatment can induce complex effects on the cell cycle, impacting checkpoints like G1, S, and G2M.
- Interpreting these effects solely from growth inhibition or flow cytometry data can be ambiguous due to multiple possible underlying mechanisms.
Purpose of the Study:
- To develop a simulation tool integrating microscopic cellular responses with experimental data to better understand drug-induced cell cycle perturbations.
- To propose an experimental plan combining various analyses for a comprehensive assessment of drug effects on cell cycle dynamics.
- To investigate the time- and dose-dependent cytostatic and cytotoxic effects of melphalan on cancer cell lines.
Main Methods:
- Developed a simulation tool linking cellular responses (G1, S, G2M) to experimental data (growth inhibition, flow cytometry).
- Proposed an experimental plan: time-course DNA flow cytometry, cell counts, DNA-Bromodeoxyuridine, and TUNEL assays with computer simulation.
- Applied the approach to study melphalan's effects on three cancer cell lines.
Main Results:
- Multiple, non-intuitive combinations of cytostatic and cytotoxic effects can explain observed data.
- Integrated data analysis significantly reduces ambiguity in interpreting cell cycle perturbations.
- Melphalan treatment caused cell cycle blocks and lethality across all phases, with dynamics varying by dose and cell line.
Conclusions:
- The developed simulation tool and experimental plan provide a clearer understanding of drug-induced cell cycle phenomena.
- This approach enhances the appreciation of time- and dose-dependent cytostatic and cytotoxic effects.
- Understanding these dynamics can support rational drug design and therapeutic strategies.
